Genetics of obsessive-compulsive disorders: New findings and challenges

Brain and Development

Volumn 25, Issue SUPPL. 1, 2003, Pages

  Grados, Marco A ^a,b   Walkup, John ^a   Walford, Samuel ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Association; Genetics; Linkage; Obsessive compulsive disorder

Indexed keywords

ANXIETY DISORDER; CONFERENCE PAPER; FUNCTIONAL ASSESSMENT; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NEUROIMAGING; NEUROPATHY; NEUROPSYCHOLOGY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; POPULATION RESEARCH; BRAIN; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVIEW;

CATECHOLAMINE; HOMEODOMAIN PROTEIN; HOXB8 PROTEIN, HUMAN; SEROTONIN;

BRAIN; CATECHOLAMINES; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HOMEODOMAIN PROTEINS; HUMANS; LINKAGE (GENETICS); OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; SEROTONIN;

EID: 2442572701     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)90010-6     Document Type: Conference Paper

References (66)

1. Nestadt G, Samuels J, Riddle M, Bienvenu OJ, III, Liang KY, LaBuda M, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:358-63.
2. Khoury MJ, McCabe LL, McCabe ER. Population screening in the age of genomic medicine. N Engl J Med 2003;348:50-8.
3. Griesenbach U, Ferrari S, Geddes DM, Alton EW. Gene therapy progress and prospects: cystic fibrosis. Gene Ther 2002;9:1344-50.
4. Nestadt G, Samuels JF, Riddle MA, Bienvenu OJ, Liang KY, Grados MA, et al. Obsessive-compulsive disorder: defining the phenotype. J Clin Psychiatry 2002;63(S6):5-7.
5. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-71.
6. Pauls DL, Raymond CL, Stevenson JM, Leckman JF. A family study of Gilles de la Tourette syndrome. Am J Hum Genet 1991;48:154-63.
7. Grades MA, Riddle MA, Samuels JF, Liang KY, Hoehn-Saric R, Bienvenu OJ, et al. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biol Psychiatry 2001;50:559-65.
8. Leckman JF, Chittenden EH. Gilles de La Tourette's syndrome and some forms of obsessive-compulsive disorder may share a common genetic diathesis. Encephale 1990;16:321-3.
9. Nestadt G, Samuels J, Riddle MA, Liang KY, Bienvenu OJ, Hoehn-Saric R, et al. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med 2001;31:481-7.
10. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Stic R, Liang KY, Cullen BA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000;48:287-93.
11. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Brit J Psychiatry 1998;35:26-37.
12. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56:913-9.
13. Insel TR, Winslow JT. Neurobiology of obsessive compulsive disorder. Psychiatr Clin North Am 1992;15:813-24.
14. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 1992;49:690-4.
15. Rauch SL. Neuroimaging research and the neurobiology of obsessive-compulsive disorder: where do we go from here? Biol Psychiatry 2000;47:168-70.
16. Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996;53:109-13.
17. Rosenberg DR, Dick EL, O'Heam KM, Sweeney JA. Response-inhibition deficits in obsessive-compulsive disorder: an indicator of dysfunction in frontostriatal circuits. J Psychiatry Neurosci 1997;22:29-38.
18. Alsobrook II JP, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet 1999;88:669-75.
19. Leckman JF, Pauls DL, Zhang H, Rosario-Campos MC, Katsovich L, Kidd KK, et al. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet 2003;116:60-8.
20. Swedo SE. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 1994;272:1788-91.
21. Lougee L, Perlmutter SJ, Nicolson R, Garvey MA, Swedo SE. Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry 2000;39:1120-6.
22. Murphy TK, Benson N, Zaytoun A, Yang M, Braylan R, Ayoub E, et al. Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. J Neuroimmunol 2001;120:146-51.
23. Inouye E. Similar and dissimilar manifestations of obsessive-compulsive neurosis in monozygotic twins. Am J Psychiatry 1965;121:1171-5.
24. Torgerson S. Genetic factors in anxiety disorders. Arch Gen Psychiatry 1983;40:1085-9.
25. Carey G, Gottesman II. Twin and family studies of anxiety, phobic and obsessive disorders. In: Klein DF, Radkin JG, editors. Anxiety: New Research and Changing Concepts. New York, NY: Raven Press, 1981.
26. Black DW, Goldstein RB, Noyes R Jr, Blum N. Psychiatric disorders in relatives of probands with obsessive-compulsive disorder and co-morbid major depression or generalized anxiety. Psychiatr Genet 1995;5:37-41.
27. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.
28. Lenane MC, Swedo SE, Leonard H, Pauls DL, Sceery W, Rapoport IL. Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry 1990;29:407-12.
29. Riddle MA, Scahill L, King R, Hardin MT, Towbin KE, Ort SI, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry 1990;29:766-72.
30. Rasmussen SA, Tsuang MT. The epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1984;45:450-7.
31. Clifford CA, Murray RM, Fulker DW. Genetic and environmental influences on obsessional traits and symptoms. Psychol Med 1984;14:791-800.
32. Jonnal AH, Gardner CO, Prescott CA, Kendler KS. Obsessive and compulsive symptoms in a general population sample of female twins. Am J Med Genet 2000;96:791-6.
33. Bellodi L, Sciuto G, Diaferia G, Ronchi P, Smeraldi E. Psychiatric disorders in the families of patients with obsessive-compulsive disorder. Psychiatry Res 1992;42:111-20.
34. Last CG, Hersen M, Kazdin A, Orvaschel H, Perrin S. Anxiety disorders in children and their families. Arch Gen Psychiatry 1991;48:928-34.
35. Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 1999;88:38-43.
36. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 2002;114:541-52.
37. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-31.
38. Herbst JH, Zonderman AB, McCrae RR, Costa PT Jr. Do the dimensions of the temperament and character inventory map a simple genetic architecture? Evidence from molecular genetics and factor analysis. Am J Psychiatry 2000;157:1285-90.
39. Camarena B, Rinetti G, Cruz C, Hernandez S, de IF Jr, Nicolini H. Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder. Int J Neuropsychopharmacol 2001;4:269-72.
40. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, et al. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry 1999;4:463-6.
41. McDougle CJ, Epperson CN, Price LH, Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 1998;3:270-3.
42. Mundo E, Richter MA, Sam F, Macciardi F, Kennedy JL. Is the 5-HT(1Dβ) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder? Am J Psychiatry 2000;157:1160-1.
43. Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, et al. 5HT1Dβ Receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Mol Psychiatry 2002;7:805-9.
44. Di Bella D, Cavallini MC, Bellodi L. No association between obsessive-compulsive disorder and the 5-HT(1Dβ) receptor gene. Am J Psychiatry 2002;159:1783-5.
45. Erfurth A, Schmauss M. Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature. Nervenarzt 1993;64:70-2.
46. Hotamisligil GS, Breakefield XO. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1991;49:383-92.
47. Camarena B, Rinetti G, Cruz C, Gomez A, de IF Jr, Nicolini H. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet 2001;105:279-82.
48. Camarena B, Cruz C, de IF Jr, Nicolini H. A higher frequency of a low activity-related allele of the MAO-A gene in females with obsessive-compulsive disorder. Psychiatr Genet 1998;8:255-7.
49. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 1999;45:1178-89.
50. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6:243-50.
51. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A 1997;94:4572-5.
52. Schindler KM, Richter MA, Kennedy JL, Pato MT, Pato CN. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet 2000;96:721-4.
53. Niehaus DJ, Kinnear CJ, Cotield VA, du Toit PL, van Kradenburg J, Moolman-Smook JC, et al. Association between a catechol-O-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. J Affect Disord 2001;65:61-5.
54. Alsobrook JP, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet 2002;114:116-20.
55. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994;182:476-8.
56. Baldessarini RJ, Tarazi FI. Brain dopamine receptors: a primer on their current status, basic and clinical. Harvard Rev Psychiatry 1996;3:301-25.
57. Tarazi FI, Baldesstini RJ. Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry 1999;4:529-38.
58. Cohen BM, Ennulat DJ, Centorrino F, Matthysse S, Konieczna H, Chu HM, et al. Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs. Psychopharmacology (Berl) 1999;141:6-10.
59. Cruz C, Camarena B, King N, Paez F, Sidenberg D, de IF Jr, et al. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci Lett 1997;231:1-4.
60. Nicolini H, Cruz C, Paez F, Camarena B. Dopamine D2 and D4 receptor genes distinguish the clinical presence of tics in obsessive-compulsive disorder. Gaceta Medica Mexico 1998;134:521-7.
61. Billett EA, Richter MA, Sam F, Swinson RP, Dai XY, King N, et al. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr Genet 1998;8:163-9.
62. Capecchi MR. Hox genes and mammalian development. Cold Spring Harb Symp Quant Biol 1997;62:273-81.
63. Greer JM, Capecchi MR. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002;33:23-34.
64. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 2003;73:370-6.
65. Wu A, Molteni R, Ying Z, Gomez-Pinilla F. A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neurosci 2003;119:365-75.
66. Poser S, Impey S, Xia Z, Storm DR. Brain-derived neurotrophic factor protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J Neurosci 2003;23:4420-7